Vanda Pharmaceuticals Announces Participation at November 2026 Investor Conferences
Vanda Pharmaceuticals (VNDA) will participate in five investor conferences in New York City and London during November 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Vanda Pharmaceuticals (VNDA) will participate in five investor conferences in New York City and London during November 2026.
New York appearances include Wolfe Research on November 10, Stifel on November 11 and Truist Securities on November 12. London appearances include UBS on November 17 and Jefferies on November 19. The Stifel and Jefferies fireside chats will be webcast live through Vanda's website, with archives available for approximately 30 days.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The 8th Annual Wolfe Research Healthcare Conference in
The Stifel 2026 Healthcare Conference in
The Truist Securities 2026 Biopharma Symposium in
The UBS Global Biopharma Conference in
The Jefferies Global Healthcare Conference in
The fireside chats at the Stifel 2026 Healthcare Conference and Jefferies Global Healthcare Conference may be accessed live on Vanda's corporate website, www.vandapharma.com. Investors should click on the Investors tab and follow the link under Recent Events. Investors are advised to go to the conference website at least 15 minutes early to register, download, and install any necessary software or presentations. A link to the archived conference will be available on Vanda's website for a period of approximately 30 days.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-november-2026-investor-conferences-302928314.html
SOURCE Vanda Pharmaceuticals Inc.